MYRIAD GENETICS INC of SALT LAKE CITY, UT filed a DEFA14A with the SEC on 2026-04-14. Industry: In Vitro & In Vivo Diagnostic Substances.
| Seq | Type | Description |
|---|---|---|
| 1 | DEFA14A | DEFA14A |
| 2 | GRAPHIC | capture5a.jpg |
| 3 | GRAPHIC | capture6a.jpg |
| 4 | GRAPHIC | capture7a.jpg |
| 5 | GRAPHIC | capture8a.jpg |
Showing 12 of 60 filings.
| Filed | Form |
|---|---|
| 2026-04-14 | DEFA14A |
| 2026-04-14 | DEF 14A |
| 2025-04-09 | DEFA14A |
| 2025-04-09 | DEF 14A |
| 2024-04-17 | DEFA14A |
| 2024-04-17 | DEF 14A |
| 2023-04-12 | DEFA14A |
| 2023-04-12 | DEF 14A |
| 2023-03-30 | PRE 14A |
| 2022-04-14 | DEFA14A |
| 2022-04-14 | DEF 14A |
| 2021-04-15 | DEFA14A |